Subacute sclerosing panencephalitis as a re-emerging condition due to low vaccination coverage: a case-series
- PMID: 40483442
- PMCID: PMC12145622
- DOI: 10.1186/s13052-025-02026-3
Subacute sclerosing panencephalitis as a re-emerging condition due to low vaccination coverage: a case-series
Abstract
Background: Subacute sclerosing panencephalitis (SSPE) is a chronic progressive disease affecting the central nervous system (CNS) because of persistent measles virus (MeV) infection. The disease presents with a range of symptoms, starting with gradual cognitive and motor decline, progressing to coma, vegetative state, and typically resulting in death within 3-4 years of clinical onset. The incidence of SSPE is inversely related to vaccination coverage and its pathogenesis remains poorly understood. The primary risk factor is infection by the wild type of measles virus, particularly in individuals who may be predisposed to infection due to a lack of herd immunity or immunosuppressed states. Furthermore, the risk of developing SSPE increases with the younger age at which a person contracts measles.
Case presentation: We provide a description of the disease, characterizing its clinical course, diagnostic work-up and treatment options. We will also present a series of cases observed at the Santobono-Pausilipon Children's Hospital, in Naples, Italy, highlighting both typical and atypical presentations, with a particular emphasis on the pharmacological and neurosurgical treatments for the condition.
Conclusions: The objective of this study is to raise awareness about the increasing prevalence of conditions following the SARS-Cov2 pandemic, with an emphasis on the importance of vaccination adherence as the only effective prevention method for SSPE.
Keywords: Interferon alpha; Measles; SSPE; Seizures; Vaccine.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethical approval: No experimental procedure was performed, but only the investigations required by clinical practice. Therefore, it was not needed to submit the case to the approval of the Ethics Committee. Clinical Investigations were conducted according to the principles expressed in Declaration of Helsinki. Consent for publication: Informed consent was acquired from parents of the patients both for the diagnostic procedures required for diagnosis and for the use of data for scientific purposes in respect of privacy. Author information: We understand that the Corresponding Author is the sole contact for the Editorial process (including Editorial Manager and direct communications with the office). She is responsible for communicating with the other authors about progress, submissions of revisions and final approval of proofs. We confirm that we have provided a current, correct email address which is accessible by the Corresponding Author. Competing interests: The authors declare that they have no financial or competing interests.
Figures
References
-
- Garg RK. Subacute sclerosing panencephalitis. J Neurol. 2008;255(12):1861–71. 10.1007/s00415-008-0032-6. - PubMed
-
- Liko J, Guzman-Cottrill JA, Cieslak PR. Notes from the field: subacute sclerosing panencephalitis Death - Oregon, 2015. MMWR Morb Mortal Wkly Rep. 2016;65(1):10–1. 10.15585/mmwr.mm6501a3. Published 2016 Jan 15. - PubMed
-
- Bester JC. Measles and measles vaccination: A review. JAMA Pediatr. 2016;170(12):1209–15. 10.1001/jamapediatrics.2016.1787. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
